Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) Return on Equity (2017 - 2025)

HealthLynked (HLYK) has disclosed Return on Equity for 9 consecutive years, with 0.55% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 278.0% to 0.55% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.55%, a 278.0% decrease, with the full-year FY2024 number at 5.28%, up 63.0% from a year prior.
  • Return on Equity was 0.55% for Q3 2025 at HealthLynked, down from 0.89% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 22.37% in Q2 2024 to a low of 3.46% in Q1 2021.
  • A 5-year average of 1.3% and a median of 0.55% in 2025 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: skyrocketed 2120bps in 2024, then plummeted -2148bps in 2025.
  • HealthLynked's Return on Equity stood at 1.34% in 2021, then skyrocketed by 74bps to 0.34% in 2022, then surged by 743bps to 2.21% in 2023, then decreased by -8bps to 2.04% in 2024, then tumbled by -73bps to 0.55% in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Return on Equity are 0.55% (Q3 2025), 0.89% (Q2 2025), and 1.27% (Q1 2025).